212 related articles for article (PubMed ID: 32045660)
1. Role of regulatory miRNAs of the PI3K/AKT signaling pathway in the pathogenesis of breast cancer.
Rahmani F; Ferns GA; Talebian S; Nourbakhsh M; Avan A; Shahidsales S
Gene; 2020 May; 737():144459. PubMed ID: 32045660
[TBL] [Abstract][Full Text] [Related]
2. Tumor Suppressor miRNA-204-5p Regulates Growth, Metastasis, and Immune Microenvironment Remodeling in Breast Cancer.
Hong BS; Ryu HS; Kim N; Kim J; Lee E; Moon H; Kim KH; Jin MS; Kwon NH; Kim S; Kim D; Chung DH; Jeong K; Kim K; Kim KY; Lee HB; Han W; Yun J; Kim JI; Noh DY; Moon HG
Cancer Res; 2019 Apr; 79(7):1520-1534. PubMed ID: 30737233
[TBL] [Abstract][Full Text] [Related]
3. Role of Regulatory Oncogenic or Tumor Suppressor miRNAs of PI3K/AKT Signaling Axis in the Pathogenesis of Colorectal Cancer.
Soleimani A; Rahmani F; Ferns GA; Ryzhikov M; Avan A; Hassanian SM
Curr Pharm Des; 2018; 24(39):4605-4610. PubMed ID: 30636581
[TBL] [Abstract][Full Text] [Related]
4. Role of regulatory miRNAs of the PI3K/AKT/mTOR signaling in the pathogenesis of hepatocellular carcinoma.
Rahmani F; Ziaeemehr A; Shahidsales S; Gharib M; Khazaei M; Ferns GA; Ryzhikov M; Avan A; Hassanian SM
J Cell Physiol; 2020 May; 235(5):4146-4152. PubMed ID: 31663122
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-214 acts as a potential oncogene in breast cancer by targeting the PTEN-PI3K/Akt signaling pathway.
Wang F; Li L; Chen Z; Zhu M; Gu Y
Int J Mol Med; 2016 May; 37(5):1421-8. PubMed ID: 26951965
[TBL] [Abstract][Full Text] [Related]
6. Suppression of SPIN1-mediated PI3K-Akt pathway by miR-489 increases chemosensitivity in breast cancer.
Chen X; Wang YW; Xing AY; Xiang S; Shi DB; Liu L; Li YX; Gao P
J Pathol; 2016 Aug; 239(4):459-72. PubMed ID: 27171498
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-520a-3p inhibits cell growth and metastasis of non-small cell lung cancer through PI3K/AKT/mTOR signaling pathway.
Lv X; Li CY; Han P; Xu XY
Eur Rev Med Pharmacol Sci; 2018 Apr; 22(8):2321-2327. PubMed ID: 29762835
[TBL] [Abstract][Full Text] [Related]
8. miR-218 inhibits the invasion and migration of colon cancer cells by targeting the PI3K/Akt/mTOR signaling pathway.
Zhang X; Shi H; Tang H; Fang Z; Wang J; Cui S
Int J Mol Med; 2015 May; 35(5):1301-8. PubMed ID: 25760926
[TBL] [Abstract][Full Text] [Related]
9. miRs-134 and -370 function as tumor suppressors in colorectal cancer by independently suppressing EGFR and PI3K signalling.
El-Daly SM; Abba ML; Patil N; Allgayer H
Sci Rep; 2016 Apr; 6():24720. PubMed ID: 27095166
[TBL] [Abstract][Full Text] [Related]
10. The emerging role of noncoding RNAs in the PI3K/AKT/mTOR signalling pathway in breast cancer.
Abu-Alghayth MH; Khan FR; Belali TM; Abalkhail A; Alshaghdali K; Nassar SA; Almoammar NE; Almasoudi HH; Hessien KBG; Aldossari MS; Binshaya AS
Pathol Res Pract; 2024 Mar; 255():155180. PubMed ID: 38330621
[TBL] [Abstract][Full Text] [Related]
11. LHX6 inhibits the proliferation, invasion and migration of breast cancer cells by modulating the PI3K/Akt/mTOR signaling pathway.
Bi QJ; Men XJ; Han R; Li GL
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3067-3073. PubMed ID: 29863252
[TBL] [Abstract][Full Text] [Related]
12. MEG3 overexpression inhibits the tumorigenesis of breast cancer by downregulating miR-21 through the PI3K/Akt pathway.
Zhu M; Wang X; Gu Y; Wang F; Li L; Qiu X
Arch Biochem Biophys; 2019 Jan; 661():22-30. PubMed ID: 30389444
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-122 promotes proliferation, invasion and migration of renal cell carcinoma cells through the PI3K/Akt signaling pathway.
Lian JH; Wang WH; Wang JQ; Zhang YH; Li Y
Asian Pac J Cancer Prev; 2013; 14(9):5017-21. PubMed ID: 24175769
[TBL] [Abstract][Full Text] [Related]
14. ILK promotes cell proliferation in breast cancer cells by activating the PI3K/Akt pathway.
Qu Y; Hao C; Xu J; Cheng Z; Wang W; Liu H
Mol Med Rep; 2017 Oct; 16(4):5036-5042. PubMed ID: 28791358
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-204 inhibits the proliferation and metastasis of breast cancer cells by targeting PI3K/AKT pathway.
Fan X; Fang X; Liu G; Xiong Q; Li Z; Zhou W
J BUON; 2019; 24(3):1054-1059. PubMed ID: 31424660
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.
Vilquin P; Donini CF; Villedieu M; Grisard E; Corbo L; Bachelot T; Vendrell JA; Cohen PA
Breast Cancer Res; 2015 Jan; 17(1):13. PubMed ID: 25633049
[TBL] [Abstract][Full Text] [Related]
17. Activation of PI3K/Akt/mTOR signaling in the tumor stroma drives endocrine therapy-dependent breast tumor regression.
Polo ML; Riggio M; May M; Rodríguez MJ; Perrone MC; Stallings-Mann M; Kaen D; Frost M; Goetz M; Boughey J; Lanari C; Radisky D; Novaro V
Oncotarget; 2015 Sep; 6(26):22081-97. PubMed ID: 26098779
[TBL] [Abstract][Full Text] [Related]
18. Knocking down FAM83B inhibits endometrial cancer cell proliferation and metastasis by silencing the PI3K/AKT/mTOR pathway.
Lin Q; Chen H; Zhang M; Xiong H; Jiang Q
Biomed Pharmacother; 2019 Jul; 115():108939. PubMed ID: 31079003
[TBL] [Abstract][Full Text] [Related]
19. Novel approaches for molecular targeted therapy of breast cancer: interfering with PI3K/AKT/mTOR signaling.
Grunt TW; Mariani GL
Curr Cancer Drug Targets; 2013 Feb; 13(2):188-204. PubMed ID: 23215720
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-218-5p inhibit the migration and proliferation of pterygium epithelial cells by targeting EGFR via PI3K/Akt/mTOR signaling pathway.
Han S; Chen Y; Gao Y; Sun B; Kong Y
Exp Eye Res; 2019 Jan; 178():37-45. PubMed ID: 30243568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]